Comparative Study of OPC-1085EL Ophthalmic Solution to Carteolol Hydrochloride Long-Acting Ophthalmic Solution 2% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension (Phase 3 study)
Phase 3
- Conditions
- Glaucoma or ocular hypertension
- Registration Number
- JPRN-jRCT2080222438
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 175
Inclusion Criteria
Subjects with bilateral primary open-angle glaucoma or ocular hypertension
Exclusion Criteria
Subjects with ocular conditions as defined by the protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure
- Secondary Outcome Measures
Name Time Method Efficacy: intraocular pressure<br>Safety